06 Mar 2024 Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024 Therapeutics
19 Jan 2024 Appointment of Christina Coughlin, M.D., Ph.D. as Head of Research and Development Investors | Therapeutics